New Guidelines Available For the Management of Thyroid Cancer
New-evidence based recommendations from the American Thyroid Association (ATA) have been released.
All articles by Mehreen Dharsee
Anticoagulant Reversal Agent Idarucizumab Receives Accelerated Approval
Idarucizumab (Praxbind) was recently granted accelerated approval by the FDA as a reversal agent.
Survival Benefit Associated With Chemoradiotherapy in Older Patients
Chemoradiotherapy (CRT) may provide additional overall survival (OS) benefit in older patients with limited-stage small-cell lung cancer.
Impact of Reproductive Factors, Exogenous Hormones in Multiple Myeloma Risk Evaluated
Although female sex hormones are known to have immunomodulatory effects, they may not significantly affect the risk of multiple myeloma,
Visceral Pleural Invasion May Impact Survival in Node-Negative NSCLC
Visceral pleural invasion (VPI) may have an impact on survival in node-negative non-small cell lung cancer (NSCLC).
Cardiovascular Effects of Chemo-Radiation in Hodgkin’s Lymphoma Analyzed
Certain doses of radiation and anthracycline therapy for the treatment of Hodgkin’s lymphoma may increase the risk of cardiovascular events.
Poor Outcomes Observed in CLL Patients Diagnosed With Acute Leukemia, MDS
Acute leukemia (AL) or myelodysplastic syndrome (MDS) in chronic lymphocytic leukemia (CLL) is associated with poorer outcomes.
Genetic Variants, Treatment Response in B-Cell Lymphoma Investigated
Evidence of inherited genetics contributing to response in patients receiving immunochemotherapy for diffuse large B-cell lymphoma (DLBCL).
Mutations in Triple Negative Essential Thrombocytopenia Detected
Atypical mutations were found in the thrombopoietin receptor (MPL) in patients with triple negative essential thrombocytopenia.
No Survival Advantage Displayed With Transarterial Chemoembolization
Addition of transarterial chemoembolization to sorafenib for treatment of hepatocellular carcinoma (HCC) displayed no survival advantage.
- Loading...
Loading...
Next post in Gastrointestinal Cancers
Loading... 
Loading...